{"id":"https://openalex.org/W4399324569","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps1141","title":"A phase II trial to assess the impact of \u03b22 adrenergic blockade in immune checkpoint inhibitor (ICI)\u2013 refractory metastatic triple negative breast cancer (mTNBC).","display_name":"A phase II trial to assess the impact of \u03b22 adrenergic blockade in immune checkpoint inhibitor (ICI)\u2013 refractory metastatic triple negative breast cancer (mTNBC).","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399324569","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps1141"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps1141","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps1141","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps1141","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS1141","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS1141","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064151962","display_name":"Shipra Gandhi","orcid":"https://orcid.org/0000-0003-3506-0284","observed_orcids":["https://orcid.org/0000-0003-3506-0284"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shipra Gandhi","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032765285","display_name":"Arya Mariam Roy","orcid":"https://orcid.org/0000-0003-2509-312X","observed_orcids":["https://orcid.org/0000-0003-2509-312X"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arya Mariam Roy","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033083387","display_name":"Hans Minderman","orcid":"https://orcid.org/0000-0003-4987-9266","observed_orcids":["https://orcid.org/0000-0003-4987-9266"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans Minderman","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009152250","display_name":"Spencer R. Rosario","orcid":"https://orcid.org/0000-0002-2626-9257","observed_orcids":["https://orcid.org/0000-0002-2626-9257"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spencer Rosario","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029344793","display_name":"Elizabeth A. Repasky","orcid":"https://orcid.org/0000-0002-9554-4152","observed_orcids":["https://orcid.org/0000-0002-9554-4152"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Repasky","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"TPS1141","last_page":"TPS1141"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.9819999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8019999861717224},{"id":"https://openalex.org/keywords/immune-exhaustion","display_name":"immune exhaustion","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cytotoxic-cd8-t-cells","display_name":"CD8+ cytotoxic T lymphocytes","score":0.8700000047683716},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9089999794960022},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8450000286102295},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8859243392944336},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6821584701538086},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6747766733169556},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6481544971466064},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5825788974761963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5285110473632812},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5215456485748291},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4724103510379791},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4187449812889099},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34760957956314087},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16774362325668335},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.tps1141","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps1141","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps1141","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS1141","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.tps1141","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps1141","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps1141","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.TPS1141","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4399324569.pdf","grobid_xml":"https://content.openalex.org/works/W4399324569.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410804839","https://openalex.org/W2947041055","https://openalex.org/W4282920778","https://openalex.org/W7134895698","https://openalex.org/W3010740851","https://openalex.org/W3011399739","https://openalex.org/W4366827791","https://openalex.org/W3163365295","https://openalex.org/W3036692211","https://openalex.org/W4392285449"],"abstract_inverted_index":{"TPS1141":[0],"Background:":[1],"In":[2,324],"PD-L1+":[3,230],"mTNBC":[4,222],"patients":[5],"(pts),":[6],"the":[7,18,62,76,90,99,106,242,340,368],"standard":[8],"of":[9,34,64,86,102,177,352,396,402],"care":[10],"treatment":[11,236],"is":[12,213,289,302,337,410],"chemotherapy":[13,238],"and":[14,40,60,70,104,239,307,317,376,380,394,400],"pembrolizumab":[15],"(P)":[16],"in":[17,75,153,158,201,241,252,267,315,389],"first-line":[19],"setting.":[20,244],"It":[21],"has":[22,272],"been":[23],"shown":[24],"that":[25,44,161,198],"acquired":[26],"resistance":[27],"to":[28,169,181,209,254,297,344],"P":[29,170,184,240,248],"occurs":[30],"as":[31,179,292],"a":[32,154,214,259,350],"result":[33],"immune":[35,319],"exhaustion.":[36],"Further,":[37],"our":[38,263],"group":[39],"others":[41],"have":[42,151,233],"demonstrated":[43,122,273],"chronic":[45],"\u03b22-adrenergic":[46],"receptor":[47],"(\u03b2-AR)":[48],"signaling":[49,88],"suppresses":[50],"CD8+":[51],"cytotoxic":[52],"T":[53,72],"lymphocytes":[54],"(CTL)":[55],"function,":[56],"drives":[57],"their":[58],"exhaustion,":[59],"increases":[61],"numbers":[63],"immunosuppressive":[65],"myeloid-derived":[66],"suppressor":[67],"cells":[68,73],"(MDSCs)":[69],"regulatory":[71],"(Tregs)":[74],"tumor":[77,82,119,316,378],"microenvironment":[78],"(TME),":[79],"thus":[80],"supporting":[81],"proliferation.":[83],"Consequently,":[84],"abrogation":[85],"\u03b2-AR":[87,132,162],"using":[89,199],"pan":[91],"\u03b2-blocker":[92],"propranolol":[93,136,165,200,257],"or":[94,294],"\u03b2-AR-/-":[95],"knockout":[96],"mice":[97],"increased":[98,167],"intratumoral":[100],"frequency":[101,395],"CTLs":[103,130],"elevated":[105],"CTL:Treg":[107],"ratio":[108],"(Bucsek":[109],"et":[110,139,187],"al.":[111,140],"Cancer":[112,141,190],"Res.":[113,143],"2017;":[114],"PMID:":[115,145,193],"28819022).":[116],"Similarly,":[117],"mouse":[118],"models":[120],"also":[121],"decreased":[123],"exhaustion":[124,403],"markers":[125,320,404],"(PD1,":[126,405],"TIM3,":[127,406],"LAG3)":[128],"on":[129,235,262],"when":[131],"was":[133],"blocked,":[134],"via":[135],"(Qiao":[137],"G":[138],"Immunol":[142],"2021,":[144,192],"33762351).":[146],"Confirming":[147],"this":[148,276],"phenomenon,":[149],"we":[150,196],"shown,":[152],"prospective":[155],"clinical":[156,265],"trial":[157,266,414],"metastatic":[159,268],"melanoma,":[160],"blockade":[163],"with":[164,171,183,229,237,275],"significantly":[166],"response":[168,174,296,336],"an":[172,202,311],"objective":[173],"rate":[175],"(ORR)":[176],"78%,":[178],"opposed":[180],"30-40%":[182],"monotherapy":[185],"(Gandhi":[186],"al,":[188],"Clin":[189],"Res":[191],"33127652).":[194],"Therefore,":[195],"hypothesize":[197],"ICI":[203],"refractory":[204],"population":[205],"should":[206],"improve":[207],"responses":[208,364],"ICIs.":[210],"Methods:":[211],"This":[212],"phase":[215],"II":[216],"single-arm,":[217],"non-randomized":[218],"single-center":[219],"study":[220,341,409],"for":[221,349,359,387],"pts.":[223],"Participants":[224],"will":[225,246,279,321,330,342,356,371,384],"bewomen":[226],">=18":[227],"yrs":[228],"mTNBC,":[231],"who":[232],"progressed":[234],"upfront":[243],"They":[245],"continue":[247,280,343],"every":[249],"3":[250],"weeks":[251],"addition":[253],"30":[255],"mg":[256],"twice":[258],"day,":[260],"based":[261],"ongoing":[264],"melanoma":[269],"(NCT03384836)":[270],"which":[271],"safety":[274],"combination.":[277],"Treatment":[278],"until":[281],"disease":[282],"progression":[283],"per":[284],"irRECIST.":[285],"The":[286,299,408],"primary":[287],"endpoint":[288,301],"ORR,":[290],"defined":[291],"complete":[293],"partial":[295],"treatment.":[298],"secondary":[300],"safety,":[303],"6-month":[304],"progression-free":[305],"survival":[306],"overall":[308],"survival.":[309],"As":[310],"exploratory":[312],"endpoint,":[313],"changes":[314,388],"blood":[318,382],"be":[322,331,357,372,385],"assessed.":[323],"stage":[325],"1,":[326],"n1=12":[327],"evaluable":[328],"pts":[329,348],"enrolled.":[332],"If":[333,361],"\u2265":[334,362],"1/12":[335],"observed,":[338,366],"then":[339,367],"enroll":[345],"another":[346],"n2=9":[347],"total":[351],"n=21,":[353],"otherwise":[354],"it":[355],"suspended":[358],"futility.":[360],"3/21":[363],"are":[365],"proposed":[369],"therapy":[370],"considered":[373],"promising.":[374],"Pre-":[375],"post-treatment":[377],"biopsies":[379],"sequential":[381],"samples":[383],"analyzed":[386],"stress-induced":[390],"biomarkers":[391],"(epinephrine,":[392],"norepinephrine,":[393],"CTL,":[397],"MDSC,":[398],"Treg)":[399],"expression":[401],"LAG3).":[407],"currently":[411],"open.":[412],"Clinical":[413],"information:":[415],"NCT05741164":[416],".":[417]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-05T00:00:00"}